2013
DOI: 10.1016/j.carbpol.2013.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Novel microparticulate systems for the vaginal delivery of nystatin: Development and characterization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
22
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(26 citation statements)
references
References 33 publications
1
22
0
1
Order By: Relevance
“…Microencapsulation was proposed as a method to protect and ensure drug's delivery in specific tracts [19]. Nowadays, microencapsulation and freeze drying represent appropriate strategies to maintain the viability and stability of probiotics for use in both food and pharmaceutical technologies [24,25].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Microencapsulation was proposed as a method to protect and ensure drug's delivery in specific tracts [19]. Nowadays, microencapsulation and freeze drying represent appropriate strategies to maintain the viability and stability of probiotics for use in both food and pharmaceutical technologies [24,25].…”
Section: Resultsmentioning
confidence: 99%
“…The microcapsules help fragile and sensitive materials to survive processing and packaging conditions and stabilize the shelf life of the active ingredient [26]. Also, the mucoadhesive properties of selected polymers promote intimate contact between the pharmaceutical form and the vaginal tissue and prolong the residence-time at the administration site [19]. Therefore, in this work the microencapsulation of bovine vaginal probiotics in alginate-MCs was studied.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…imizadole and nystatin) microspheres [163][164][165] and nanospheres [166]. This strategy aims at improving drug retention in the vagina, due to their mucoadhesive properties while allowing for controlled drug release with no loss or eventually enhancement of anti-Candida activity [164].…”
Section: Several Authors Used Mucoadhesive Polymers Such As Eudragit®mentioning
confidence: 99%
“…Microparticulate drug delivery systems—multiunit carriers composed of spherical particles with average diameter 1–500 μm—have gained particular interest in the pharmaceutical field, due to their ability to assure prolonged drug release profile, providing stability of labile substances or reducing toxicity of active agents [1,2]. In addition, a large surface area of the microparticles enables assuring more uniform drug absorption, which might be favorable, especially with respect to topical delivery vehicles [3].…”
Section: Introductionmentioning
confidence: 99%